Full Breakdown
Trump Promises $50-Per-Month GLP-1 Drug Prices Ahead of 2026 Midterms
6/25/2026, 2:02:10 AM
Core Announcement at Mack Trucks Plant
President Donald Trump addressed workers at a Mack Trucks plant in Lehigh Valley, Pennsylvania, on Tuesday, announcing that Medicare beneficiaries will be able to obtain GLP-1 weight-loss drugs for $50 per month starting July 1. He asserted the price cuts would alone secure Republican victories in the 2026 midterm elections.
Background: GLP-1 Drugs and Medicare Coverage
GLP-1 drugs such as Wegovy, Ozempic, Zepbound and Foundayo are used to treat obesity, type-2 diabetes and related cardiovascular risk. Before the announcement, Medicare Part D covered these drugs only for diabetes or heart disease; otherwise seniors paid out-of-pocket, often exceeding $1,200 monthly.
Data on Price Reductions
The TrumpRx portal reports Wegovy’s average monthly price fell from $1,349 to $149, while the White House cites a floor of $199 depending on dosage. Ozempic’s price dropped from $1,028 to $350 on both the portal and official data. The $50 per month figure exceeds these disclosed amounts.
Official Statements & Government Responses
The White House issued fact sheets confirming manufacturer agreements have lowered GLP-1 costs and that eligible Medicare beneficiaries will gain coverage on July 1. CMS verified the upcoming policy change. Trump emphasized the measure’s potential to improve public health, reduce healthcare spending and increase household disposable income.
Criticism & Political Context
White House officials denied reports that President Trump is personally using a weight-loss drug, separating policy promotion from personal health. Separate analysis notes his economic approval rating has fallen since the February Iran conflict, suggesting voter skepticism toward his broader economic narrative. The $50 per month figure lacks independent verification, as price data from the TrumpRx site and White House fact sheets differ.
Conflicting Reports & Gaps
Trump’s $50-per-month claim conflicts with White House-published prices of $199 for Wegovy and $350 for Ozempic. The TrumpRx site lists Wegovy at $149, creating a discrepancy without independent verification of overall Medicare savings.
Why It Matters / Impact
If sustained, lower drug costs could reduce seniors’ out-of-pocket spending and obesity-related health expenditures. Politically, the policy is positioned as a decisive benefit for Republican candidates in the 2026 midterms.
Verbatim Quotes
- “Starting next week, weight loss drugs will be available for just $50 — think of that‚ for seniors who previously had to pay $1,200,$1,300, $1,400,” — President Donald Trump
- “These are the biggest price reductions in the history of our country for anything having to do with drugs, prescription medicine. So that alone should win the midterms,” — President Donald Trump
- “Oil is going to come charging down and with oil comes everything else,” — President Donald Trump
- “We’re trying to work out a deal that’s fair,” — President Donald Trump
What’s Next
Medicare enrollment for the GLP-1 program begins July 1; the administration will track uptake while GOP candidates highlight the policy.
